跳至主要内容
临床试验/NCT01160900
NCT01160900Unknown3 期

Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction

Azienda Ospedaliera San Camillo Forlanini2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
3 期
入组人数
180
试验地点
2
主要终点
death at 30 days

研究概览

简要总结

Few reports described outcomes of complete compared with infarct related artery (IRA) only revascularization in patients with ST elevation myocardial infarction (STEMI) and multivessel coronary disease (CAD).

The purpose of this study is to determine outcome (death, myocardial infarction, target vessel failure) of 180 consecutive patients with STEMI and multivessel CAD undergoing primary angioplasty.

Before the first angioplasty patients are randomized to 2 different strategies: 1) culprit vessel angioplasty only, 2) staged revascularization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • myocardial acute infarction
  • prolonged chest pain (>20 minute) started less <12 hours before arrive in hospital
  • ST segment elevation of >1mm in >2 contiguous leads
  • new left bundle branch block
  • diameter of the coronary suitable of angioplasty >2mm
  • the patients agrees to the study protocol and provides a written consensus
  • two or more coronary suitable for angioplasty

排除标准

  • refused written consensus
  • hypersensitivity or contraindication to any of the following medications: heparin bivalirudin aspirin prasugrel stainless steel
  • history of bleeding
  • cardiogenic shock (PA < 90mmHg)
  • chronic total occlusion in the second lesion
  • TIMI Flow < II in the culprit lesion
  • recent pregnancy
  • history of intra-cerebral major hemorrhagic stroke
  • an elective surgical procedure is planned that would necessitate interruption of thienopyridines during the first six months post enrollment life expectancy <1 year

结局指标

主要结局

death at 30 days

时间窗: 1 month

stent thrombosis

时间窗: 1 year

target vessel failure

时间窗: 1 year

re-acute myocardial infarction

时间窗: 1 month

次要结局

  • bleeding(1 month)
  • timi frame count(1 day)
  • vascular site access complications(1 month)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验